학술논문

Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells
Document Type
article
Source
Molecular Cell. 65(6)
Subject
Biochemistry and Cell Biology
Biomedical and Clinical Sciences
Biological Sciences
Immunology
Oncology and Carcinogenesis
Cancer
Breast Cancer
Aetiology
2.1 Biological and endogenous factors
Antineoplastic Agents
Hormonal
Breast Neoplasms
Cytokines
Dose-Response Relationship
Drug
Drug Resistance
Neoplasm
Estrogen Receptor alpha
Female
Gene Expression Regulation
Neoplastic
HeLa Cells
Hep G2 Cells
Humans
I-kappa B Kinase
Inflammation Mediators
Interleukin-1beta
MCF-7 Cells
Molecular Dynamics Simulation
Neoplasms
Hormone-Dependent
Phosphorylation
Protein Conformation
RNA Interference
Selective Estrogen Receptor Modulators
Signal Transduction
Structure-Activity Relationship
Tamoxifen
Transcription
Genetic
Transfection
Tumor Microenvironment
Tumor Necrosis Factor-alpha
Hela Cells
breast cancer
crystallography
cytokines
drug resistance
estrogen receptor
inflammation
tamoxifen
Medical and Health Sciences
Developmental Biology
Biological sciences
Biomedical and clinical sciences
Health sciences
Language
Abstract
Human breast cancers that exhibit high proportions of immune cells and elevated levels of pro-inflammatory cytokines predict poor prognosis. Here, we demonstrate that treatment of human MCF-7 breast cancer cells with pro-inflammatory cytokines results in ERα-dependent activation of gene expression and proliferation, in the absence of ligand or presence of 4OH-tamoxifen (TOT). Cytokine activation of ERα and endocrine resistance is dependent on phosphorylation of ERα at S305 in the hinge domain. Phosphorylation of S305 by IKKβ establishes an ERα cistrome that substantially overlaps with the estradiol (E2)-dependent ERα cistrome. Structural analyses suggest that S305-P forms a charge-linked bridge with the C-terminal F domain of ERα that enables inter-domain communication and constitutive activity from the N-terminal coactivator-binding site, revealing the structural basis of endocrine resistance. ERα therefore functions as a transcriptional effector of cytokine-induced IKKβ signaling, suggesting a mechanism through which the tumor microenvironment controls tumor progression and endocrine resistance.